Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
0.00% | 3 | |
+5.92% | 11TCr | |
+11.69% | 11TCr | |
-12.67% | 2.22TCr | |
+0.06% | 2.13TCr | |
-4.83% | 1.9TCr | |
-35.21% | 1.85TCr | |
-10.55% | 1.68TCr | |
+37.76% | 1.25TCr | |
-24.71% | 808.97Cr |
- Stock Market
- Equities
- NBRVF Stock
- News Nabriva Therapeutics plc
- Earnings Flash (NBRV) NABRIVA THERAPEUTICS Reports Q3 Revenue $9.2M